Fundraising

Fifth NTUTEC visit: licensing and biotech into the Middle East, equity dilution and a pivot to alternative protein, and why a deck needs specifics and numbers that hold up.

NTUTEC invited us to Taoyuan A8. Fourth stop, AWAREK: the core is sensor fusion thermal imaging with AI alerts. They do not build drones or robot dogs themselves; system integrators bidding on tenders bring them in.

NTUTEC invited us to Taoyuan A8. Third stop, Chenlu Technology: AI-assisted medical endoscopy, IRB cleared at Tri-Service General Hospital, TFDA under review, and the overall maturity the A8 cohort showed.

NTUTEC invited us to Taoyuan A8. Second stop, EITH: ammonia and aqueous ammonia recovery, 8+ listed-company customers, and how to explain pain point, technology, and business model in plain language when the VC does not know your field.

NTUTEC invited us to Taoyuan A8 to hear pitches. First stop, Ruomei Technology: radiative cooling, in-house AI thermal simulation, a Japan distribution push, 90+ global customers, and why this felt like a real industrial company.

On my fourth NTUTEC visit with a team, I distilled three takeaways: VC follow-up timelines, the value of honest weakness disclosure, and the compounding power of cross-circle networking.

Visiting NTUTEC with a pitch-training module and an investing coach. An investment manager’s takeaway: in startups, the people matter most.

From Huang Shao-Lin's SIC masterclass and Taiwan's M-shaped startup observations to a one-click VC review Prompt. Two modes: generate a Pitch Deck outline from scratch, or run a slide-by-slide brutal stress test on an existing deck.

First insights after bringing startups to NTU TEC: making money does not equal investment value, equity structure and team stability, what VCs ask in due diligence, and why honesty makes it easier to get help.